ACE-031;Myostatin inhibitory peptide 7;

ACE-031; Myostatin Inhibitory Peptide 7 is a specialized recombinant protein designed to modulate the activity of myostatin, a well-characterized negative regulator of skeletal muscle growth. By binding to and sequestering myostatin, this peptide prevents its interaction with the activin receptor type IIB, thereby promoting muscle mass development and maintenance. ACE-031 is engineered for high specificity and affinity, which allows for targeted intervention in signaling pathways associated with muscle physiology. Its unique mechanism makes it a valuable research tool for exploring muscle biology, as well as for investigating the molecular underpinnings of muscle wasting conditions. With its robust bioactivity and reliable performance in experimental settings, Myostatin Inhibitory Peptide 7 is widely utilized in diverse fields of life sciences.

Muscle Growth Research: ACE-031 has become a cornerstone in studies focused on understanding the regulation of muscle mass and the molecular mechanisms that govern myogenesis. Researchers employ this peptide in cellular and animal models to investigate the downstream effects of myostatin inhibition on muscle fiber hypertrophy, protein synthesis, and satellite cell activation. By attenuating myostatin signaling, it enables the dissection of pathways that contribute to muscle growth, providing insights into potential targets for enhancing muscle regeneration and counteracting muscle atrophy at the molecular level.

Musculoskeletal Disease Modeling: Myostatin Inhibitory Peptide 7 is frequently used in the development of animal models that mimic conditions characterized by muscle wasting and degeneration. Through its ability to increase muscle mass and strength, the peptide facilitates the creation of experimental systems that accurately recapitulate the pathophysiology of musculoskeletal disorders. These models are instrumental for the evaluation of novel therapeutic agents, the study of disease progression, and the identification of biomarkers associated with muscle health and function.

Metabolic Research: The modulation of myostatin activity by ACE-031 has significant implications for metabolic studies, particularly those examining the interplay between muscle tissue and systemic metabolism. Researchers utilize this peptide to probe the effects of increased muscle mass on glucose homeostasis, insulin sensitivity, and lipid metabolism in various model organisms. Such investigations are crucial for elucidating the broader metabolic consequences of muscle growth and for identifying potential interventions in metabolic dysfunctions associated with muscle loss.

Tissue Engineering and Regenerative Medicine: In the field of tissue engineering, Myostatin Inhibitory Peptide 7 is explored for its capacity to enhance muscle tissue formation and integration in bioengineered constructs. By promoting the proliferation and differentiation of myogenic progenitor cells, the peptide supports the development of functional muscle tissues for transplantation and in vitro modeling. Its role in optimizing scaffold design and improving the mechanical properties of engineered muscle further underscores its value in regenerative medicine applications.

Basic Muscle Physiology Studies: ACE-031 serves as an essential tool for dissecting the fundamental principles of muscle biology. Its targeted inhibition of myostatin enables researchers to study the physiological and biochemical responses of muscle to altered growth factor signaling. These investigations contribute to a deeper understanding of muscle adaptation, atrophy, recovery, and the intricate network of regulatory molecules involved in muscle tissue homeostasis.

Sports Science and Exercise Physiology: Myostatin Inhibitory Peptide 7 is also utilized in research exploring the effects of myostatin blockade on exercise performance, muscle adaptation to training, and recovery from injury or disuse. By modulating muscle growth pathways, it provides a framework for studying the potential of targeted interventions to enhance physical performance, accelerate rehabilitation, and mitigate the effects of muscle disuse. These studies inform the development of evidence-based strategies for optimizing muscle function and resilience in various physiological and environmental contexts.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

3. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes